HEMATOLOGIC
MALIGNANCIES
The Hematologic Malignancies (HEM) research program focuses on advancing our understanding of molecular pathogenesis and treatment of leukemias and lymphomas.
About the ProgramMEMBERSHIP RESOURCES
EVENTS
Recent Publications by HEM Members
Changing the Course of Blood Cancer
Thomas Kipps, MD, PhD, is redefining what’s possible in the fight against blood cancers. That journey began early in his career, when he became captivated by the biology of leukemia, exploring what distinguishes leukemia (blood cancer) cells from normal blood cells and how they evolve in response to therapy. Leveraging his training in immunology, genetics and hematology, he committed himself to transforming blood cancer from a life-limiting diagnosis into a treatable, and potentially curable, disease.
